Background {#Sec1}
==========

Elbow stiffness is a well-recognized disabling condition that causes functional impairment in the upper limb and interferes with daily activities. It is a very common complication after injuries or secondary to arthropathy, as both bony and soft tissue factors are the most important aetiologies \[[@CR1]--[@CR3]\]. Patients with limited elbow motion usually complain of difficulties in work, leisure activities, and even basic activities of daily living. Sometimes they are troubled with symptoms like pain, numbness, weakness, and instability. Clinical scoring systems are the most popular functional measurements used in the evaluation of orthopaedic patients. These systems are used to estimate the severity of dysfunction, evaluate treatment effectiveness, and compare different treatment methods \[[@CR4], [@CR5]\].

The Liverpool Elbow Score (LES, Fig. [1](#Fig1){ref-type="fig"}) was first introduced in 2004 as an elbow-specific outcome score to be completed by both the clinicians and patients. The LES combines a nine-item patient-answered questionnaire (PAQ, P1-P9) and a six-item clinical assessment score (CAS, C1-C6) \[[@CR6]\]. The CAS comprises items that evaluate range of motion (C1-C4), muscle strength (C5), and ulnar nerve function (C6), whereas the PAQ assesses function and the ability to perform activities of daily living (P1-P7), levels of pain (P8), and participation in sporting and recreational activities (P9). The components of the LES, similar to most other elbow-related scoring systems, could also be divided into 2 parts comprising elbow motion capacities (EMC, C1-C4 and P1-P7 and P9) and elbow-related symptoms (ERS, C5-C6 and P8). ERS covers the items pertaining to muscle strength (C5) and ulnar nerve function (C6) from the CAS and pain (P8) from the PAQ. The remaining items form the EMC (C1-C4, P1-P7 and P9). In the original study, all items were measured on a scale from 0 to 10 and transformed in the calculation of the final score. The final scores were calculated as "final scores (LES) = (2/9) \* (C1 + C2 + C3 + C4 + C6) + (1/6) \* (C5 + P1 + P2 + P3 + P4 + P5 + P6 + P7 + P8 + P9)", with values ranging from 0 to 10. The lower scores represented greater symptom and functional severity. Detailed item distributions in each of the different parts along with the individual score calculations and score ranges are shown in Table [1](#Tab1){ref-type="table"}.Fig. 1The components of the Liverpool Elbow ScoreTable 1Items distribution, scores calculation and score ranges of LES and different partsPartItems distributionScores calculationScore rangesBestWorstLES (total)C1-C6, P1-P9(2/9)\* (C1 + C2 + C3 + C4 + C6) + (1/6)\* (C5 + P1 + P2 + P3 + P4 + P5 + P6 + P7 + P8 + P9)100PAQP1-P9(1/6)\* (P1 + P2 + P3 + P4 + P5 + P6 + P7 + P8 + P9)60CASC1-C6(2/9)\* (C1 + C2 + C3 + C4 + C6) + (1/6)\* (C5)40EMCC1-C4, P1-P7, P9(2/9)\* (C1 + C2 + C3 + C4) + (1/6)\* (P1 + P2 + P3 + P4 + P5 + P6 + P7 + P9)80ERSC5-C6, P8(2/9)\* (C6) + (1/6)\* (C5 + P8)20*LES* Liverpool Elbow Score, *PAQ* patient-answered questionnaire part, *CAS* clinical assessment score part, *EMC* elbow motion capacity, *ERS* elbow-related symptoms

After being demonstrated to be a reliable, valid and responsive outcome tool, the LES began to be used to assess outcomes after total elbow replacement in the management of rheumatoid arthritis \[[@CR7], [@CR8]\], posttraumatic arthritis \[[@CR8]--[@CR10]\], olecranon fractures \[[@CR10]\] and distal humeral fractures \[[@CR11], [@CR12]\]. However, there have been no published validation studies of LES for patients with stiff elbows undergoing arthrolysis. Additionally, a well-established validation study might not be applicable to different populations, which means that a previously validated tool might have to be re-validated to justify its use in different populations \[[@CR13]\]. Therefore, the purpose of this study was to determine whether the LES can be equally applied in different populations to evaluate joint function in patients with elbow stiffness.

Methods {#Sec2}
=======

Translation procedure {#Sec3}
---------------------

All the scoring systems (LES: Liverpool Elbow Score; DASH: Disability of arm, shoulder and hand questionnaire; OES: Oxford Elbow Score; MEPS: Mayo Elbow Performance Score; SF-36: Short Form-36) used in this study were translated into Simplified Chinese (Mainland) versions prior to having patients complete the questionnaires. Among these, MEPS has been widely used in China to evaluate elbow function, and validations of DASH and SF-36 have been performed in China \[[@CR14], [@CR15]\]. For LES and OES, however, there have been no other validation studies for these two scores in Simplified Chinese (Mainland) versions to this point.

Therefore, a 6-step method was used that included translation, synthesis, back-translation, expert committee review, pre-testing, and submission for appraisal, according to the guidelines of the cross-cultural adaptation process provided by Guillemin et al. \[[@CR16], [@CR17]\]. Briefly, the English versions of the LES and OES were translated separately by two native Chinese translators. A synthesized Simplified Chinese (Mainland) translation version was established after uniform agreement was reached between the two translators. The translated versions which was back-translated by two native English bilingual speakers who were blinded to the original English version. Then the four translators and two orthopaedic surgeons composed an expert committee that was established to compare the Chinese version to the original and back-translated versions. After an agreement on the semantic, idiomatic, experiential, and conceptual equivalence between the original and the target versions, and with an absence of language issues when the final version was pretested in 15 Chinese patients with elbow stiffness, the expert committee reached a consensus on the final version.

Patients and study design {#Sec4}
-------------------------

This was a retrospective validation study of patients who presented to our institution for elbow arthrolysis secondary to elbow stiffness between September 2016 and December 2016. Exclusion criteria were (1) unwillingness to participate or cooperate with follow-up; (2) illiteracy or an inability to comprehend the contents of the questionnaires; and (3) mental illness. All the patients underwent open arthrolysis by the same surgeon (C. F.) \[[@CR18]\]. During the study period, 81 patients underwent surgery for elbow stiffness at our institution. Of these, 68 met the inclusion criteria. However, 5 of the 68 were excluded because of refusal or loss to follow up. The remaining 63 included patients were 45 men and 18 women, with a mean age of 35 years and a mean follow-up time of 13 months (other demographics and characteristics are shown in Table [2](#Tab2){ref-type="table"}). The sample size of the respondents for validation of a scoring system was assumed to exceed three times the number of items in the system \[[@CR19]\]. Therefore, with a total of 15 items, a total sample size of 63 was considered sufficient. All patients were asked to complete the patient-rated parts of LES, DASH, OES and SF-36. The physician-rated parts of LES and MEPS were assessed following a written protocol so that all the patients were examined using the same method.Table 2Demographics and clinical characteristics of patientsCharacteristicsNo. of patients63Male45 (71)Age, years35 ± 13 (11--62)Height, cm169 ± 9, (143--188)Weight, Kg66 ± 13, (32--105)BMI, kg/m223.1 ± 3.4 (15.7--32.2)Dominant arm34 (54)Follow-up time^a^, months13 ± 1 (12--15)Categorical variables are presented as number (%)Continuous variables presented as mean ± standard deviation, (range)*BMI* body mass index^a^follow-up time means month post-operation from elbow release

Testing and evaluation of measurement qualities {#Sec5}
-----------------------------------------------

Floor and ceiling effects, reliability, construct validity, and responsiveness were required for a full validation of the scoring system \[[@CR20], [@CR21]\].

### Reliability {#Sec6}

Reliability measures whether the scores of the same patient show differences when implemented at different times or by different doctors (test-retest reliability), and whether the items in a domain have measured the same concept (internal consistency). However, this could not be measured due to the retrospective nature of our study.

### Construct validity {#Sec7}

Construct validity is defined as the degree to which the scores of a particular instrument are related to a gold standard test. Unfortunately, no gold standard test has been established to reflect pre- and post-arthrolysis status. The DASH can be used to measure disability in any region of the upper limb and has been shown to be valid and responsive compared to other joint-specific measures of the upper extremity, and comprises 2 parts (Disability and Symptoms) \[[@CR22]\]. The OES was reported to be a valid, reliable, and responsive self-administered instrument that can be used for several types of elbow function measurements, and it comprise 3 parts (Pain, Elbow Function and Social-psychological) \[[@CR23]\]. The DASH and OES have been shown to correlate to general health measures such as the SF-36 \[[@CR23], [@CR24]\]. Consisting of physician-rated pain, ROM, stability, and a patient-rated daily function, MEPS \[[@CR25]\] was the most widely used elbow function assessment, according to a systematic review including 980 studies and exploring trends and distributions of clinical rating systems in elbow research \[[@CR26]\]. Construct validity was assessed by correlating LES to DASH, OES, MEPS, and SF-36 (PCS and MCS) in total scores (TOTAL), PAQ, CAS, EMC and ERS. Spearman's correlation coefficients (SCCs) were calculated. In this study, the Disability portion of DASH, the Elbow Function portion of OES, and the range of motion and daily activity function portion of MEPS comprised the EMC. The symptom portion of DASH, the pain portion of OES, and the pain and stability portions of MEPS comprised the ERS. The TOTAL, PAQ, and CAS portions of the LES were correlated with the TOTAL portions of DASH, OES, MEPS, and SF-36 (PCS and MCS). EMC and ERS portions of the LES were correlated with EMC and the ERS portions of DASH, OES and MEPS, as well as the TOTAL part of SF-36 (PCS and MCS).

### Responsiveness {#Sec8}

Responsiveness measures the sensitivity in changes in preoperative and follow-up results. In our study, the effect size (ES) and standardized response mean (SRM) were calculated for the TOTAL part of LES, DASH, OES, MEPS, and SF-36 (PCS and MCS) and the EMC and ERS parts of LES, DASH, OES, MEPS, as well as CAS and PAQ parts of LES. The ES was calculated as the mean difference between the baseline scores and the follow-up scores divided by the standard deviation of the baseline scores \[[@CR27]\]. The SRM was calculated as the mean change in the scores divided by the standard deviation of the change in scores \[[@CR28]\].

Statistical analyses {#Sec9}
--------------------

All statistical analyses were performed using IBM SPSS, Version 22.0 (IBM Corp, Armonk, NY, USA). Categorical data are presented as numbers (percentages). Continuous data are presented as means ± standard deviations (range). *P* values of less than 0.05 were considered statistically significant. Floor or ceiling effects existed when more than 15% of the patient collective achieved the highest or lowest possible score on the LES \[[@CR29]\].SCC was considered strong for construct validity if the value was greater than 0.5, moderate if the value was between 0.5 and 0.35, and weak if the value was less than 0.35 \[[@CR30]\]. An ES of 0.2 to 0.5 reflected small responsiveness, 0.5 to 0.8, moderate responsiveness, and greater than 0.8, large responsiveness, as well as SRM \[[@CR31]\].

Results {#Sec10}
=======

All patients completed the PAQ with no difficulties and with no items missing or showing multiple responses. No floor or ceiling effects were found in the target population (Table [3](#Tab3){ref-type="table"}). All of the SCCs were positive except the relationship with DASH, which was scored in a different direction (Table [4](#Tab4){ref-type="table"}). The LES overall scores correlated well with all the compared total scores (*p* \< 0.001 for all), as DASH (*r* = 0.89 preoperatively and 0.86 post-operatively), OES (*r* = 0.83 and 0.79), MEPS (*r* = 0.66 and 0.49), SF-36 (PCS, *r* = 0.65 and 0.64; MCS, *r* = 0.45 and 0.68), as well as with the PAQ and CAS parts of LES. The EMC and ERS parts of LES correlated either strongly or moderately with similar parts of DASH, OES, and MEPS as well as with SF-36/PCS and SF-36/MCS preoperatively and postoperatively. All in all, the different LES parts also correlated well with DASH, OES, MEPS, and SF-36, with either high or moderate correlations in TOTAL (0.45--0.89), PAQ (0.42--0.88), CAS (0.35--0.60), EMC (0.46--0.86), and ERS (0.36--0.59).Table 3Floor and ceiling effects of LESComponentLES (No.^a^)Floor effect (%^b^)Ceiling effect (%^b^)Lower limitUpper limitTOTAL2.3 (1)9.1 (1)00PAQ0.8 (1)6.0 (1)00CAS1.1 (1)3.1 (2)01.6EMC0.8 (1)7.1 (1)00ERS1.1 (1)2.0 (4)06.4*LES* Liverpool Elbow Score, *TOTAL* total scores, *PAQ* patient-answered questionnaire part, *CAS* clinical assessment score part, *EMC* elbow motion capacity, *ERS* elbow-related symptoms^a^Number of patients showing the lowest or highest values in various parts;^b^Percent of patients achieving the lowest or highest values in various partsTable 4Construct validity. Spearman Correlation Coefficients (SCCs) between LES and DASH, OES, MEPS and SF-36TOTALPAQCASEMCERSPreoperative data DASH0.89^\*\*\*^0.88^\*\*\*^0.44^\*\*\*^0.86^\*\*\*^0.54^\*\*\*^ OES0.83^\*\*\*^0.82^\*\*\*^0.45^\*\*\*^0.82^\*\*\*^0.51^\*\*\*^ MEPS0.66^\*\*\*^0.65^\*\*\*^0.38^\*\*^0.67^\*\*\*^0.36^\*\*^ SF-36/PCS0.65^\*\*\*^0.63^\*\*\*^0.42^\*\*^0.60^\*\*\*^0.45^\*\*\*^ SF-36/MCS0.45^\*\*\*^0.42^\*\*^0.35^\*\*^0.50^\*\*\*^0.41^\*\*^Follow-up data DASH0.86^\*\*\*^0.87^\*\*\*^0.57^\*\*\*^0.72^\*\*\*^0.59^\*\*\*^ OES0.79^\*\*\*^0.87^\*\*\*^0.46^\*\*\*^0.69^\*\*\*^0.54^\*\*\*^ MEPS0.49^\*\*\*^0.53^\*\*\*^0.35^\*\*^0.46^\*\*\*^0.43^\*\*\*^ SF-36/PCS0.64^\*\*\*^0.50^\*\*\*^0.52^\*\*\*^0.52^\*\*\*^0.50^\*\*\*^ SF-36/MCS0.68^\*\*\*^0.50^\*\*\*^0.60^\*\*\*^0.60^\*\*\*^0.50^\*\*\*^*LES* Liverpool Elbow Score, *TOTAL* total scores, *PAQ* patient-answered questionnaire, *CAS* clinical assessment score, *EMC* elbow motion capacity, *ERS* elbow-related symptoms, *DASH* Disability of arm, shoulder and hand questionnaire, *OES* Oxford Elbow Score, *MEPS* Mayo Elbow Performance Score, *SF-36/PCS* physical component summary part of Short Form-36, *SF-36/MCS* mental component summary part of Short Form-36, *SCCs* Spearman Correlation Coefficients*\*\*P* \< 0.01, *\*\*\*P* \< 0.001

The LES was found to be more responsive (change from preoperative to follow up) than all the compared scores: DASH, OES, MEPS and SF-36 scores (Table [5](#Tab5){ref-type="table"}). LES showed a large (ES/SRM \> 0.8/0.8) responsiveness for TOTAL (2.80/2.24, *p* \< .001), and all parts of the PAQ, CAS, and EMC (except for ERS with a moderate responsiveness of 0.55/0.52, *p* = .001). This analysis also showed that LES was more responsive than DASH with an ES/SRM of 1.96/1.51 (*p* \< .001), OES of 2.12/1.65 (*p* \< .001), MEPS of 2.32/1.72 (*p* \< .001) and SF-36 (PCS, 1.28/0.83, *p* \< .001 and MCS, 1.28/0.98, *p* \< .001).Table 5Responsiveness of LES compared with DASH, OES, MEPS and SF-36QuestionnairesMean (SD)*P* valueESSRMPreoperativeFollow-upChangeLES TOTAL5.7 (1.3)8.8 (0.8)3.1 (1.4)\< 0.0012.80 (L)2.24 (L) PAQ3.4 (1.1)5.5 (0.5)2.1 (1.2)\< 0.0012.34 (L)1.78 (L) CAS2.3 (0.4)3.3 (0.3)1.0 (0.4)\< 0.0012.90 (L)2.34 (L) EMC3.9 (1.2)6.9 (0.7)3.0 (1.3)\< 0.0012.92 (L)2.35 (L) ERS1.8 (0.2)1.9 (0.2)0.1 (0.2)0.0010.55 (M)0.52 (M)DASH TOTAL35 (18)8 (9)27 (18)\< 0.0011.96 (L)1.51 (L) EMC27 (15)5 (8)22 (15)\< 0.0011.90 (L)1.48 (L) ERS7 (4)3 (2)4 (4)\< 0.0011.41 (L)1.04 (L)OES TOTAL61 (16)88 (9)27 (17)\< 0.0012.12 (L)1.65 (L) EMC65 (19)95 (11)30 (19)\< 0.0011.99 (L)1.61 (L) ERS74 (19)86 (11)13 (20)\< 0.0010.81 (L)0.63 (M)MEPS TOTAL65 (12)88 (7)23 (14)\< 0.0012.32 (L)1.72 (L) EMC23 (10)44 (2)22 (10)\< 0.0012.87 (L)2.11 (L) ERS42 (8)44 (6)2 (8)0.0640.26 (S)0.21 (S)SF-36 PCS60 (17)82 (17)22 (26)\< 0.0011.28 (L)0.83 (L) MCS53 (20)78 (18)24 (25)\< 0.0011.28 (L)0.98 (L)*LES* Liverpool Elbow Score, *TOTAL* total scores, *PAQ* patient-answered questionnaire, *CAS* clinical assessment score, *EMC* elbow motion capacity, *ERS* elbow-related symptoms, *DASH* Disability of arm, shoulder and hand questionnaire, *OES* Oxford Elbow Score, *MEPS* Mayo Elbow Performance Score, *PCS* physical component summary part, *MCS* mental component summary part, *SD* standard deviation, *ES* effect size, *SRM* standardized response mean(L) a large responsiveness, ES of greater than 0.8; (M) a moderate responsiveness, ES of 0.5 to 0.8; and (S) a small responsiveness, ES of less than 0.5; as well as SRM

Discussion {#Sec11}
==========

The most important finding of this study was that the LES was a valid elbow-specific scoring system to evaluate joint functions in patients with elbow stiffness, and contains both subjective and objective parameters. It is based on a 15-item tool with a scale ranging from 0 to 10 points, with higher scores indicating better function.

The LES was simple enough to be rapidly administered in clinics and there were no ceiling or floor effects in our study, which demonstrated that the distribution of LES was satisfactory. Regrettably, reliability could not be measured due to the retrospective study design. Construct validity and responsiveness were assessed for validation. Because no gold standard measurement had been established for comparison of the construct validity between elbow scores, correlations (SCCs) of LES with previously validated scoring systems were determined by 0.44--0.89 for DASH and 0.35--0.67 for MEPS. In fact, validity was shown by good correlations with DASH (*r* = 0.79; *r* = 0.89 preoperatively and 0.86 postoperatively in our study) and NHP (Nottingham Health Profile, *r* = 0.54) in the original publication study for arthritis \[[@CR6]\]. Additionally, a good correlation (SCC, 0.84; 0.66 in this study) was also shown with MEPS for patients undergoing total elbow arthroplasty \[[@CR8]\]. Currently, the method of choice to determine responsiveness remains unknown, though various statistics are available \[[@CR32]\]. The determination of the effective size (ES) and standardized response mean (SRM) in addition to the Global Perceived Effect (GPE) Score was considered to be an appropriate improvement to assess responsiveness \[[@CR33]\]. Due to the retrospective nature of the study, ES and SRM were calculated and a large responsiveness was found in LES, which were larger than DASH, OES, MEPS, and SF-36 in our study. The responsiveness of LES was found to correlate well with DASH (*r* = 0.45; 0.85 in our study) and NHP (*r* = 0.42) in the original study \[[@CR6]\]. LES was also found to have large ES (1.64; 2.80 in our study), SRM (1.25; 2.24 in our study) and GRR (Guyatt responsiveness ratio, 1.69) during the follow-up period for patients undergoing elbow arthroplasty \[[@CR32]\]. Interestingly, we found a lower responsiveness in ERS compared to DASH and OES. Our explanation for this difference was that there were extra stiffness items and quality of life items in the ERS of DASH, and the ERS of OES contains only items for pain, which would contribute to the bias of the comparison.

Recently, self-assessment scores in outcome studies are becoming more and more popular due to their financial and logistic advantages \[[@CR34]\]. However, leaving objective parameters out might miss important aspects of elbow pathology that are important in symptom assessment and are impossible to evaluate by only using a self-assessment score. These aspects include elbow instability, reduced muscle strength, and nerve dysfunction. In fact, functions and symptoms in an individual joint may not be evaluated accurately by subjective questionnaires alone \[[@CR35]\]. The questions presented to patients are also sometimes lengthy and not relevant to specific problems \[[@CR36]\]. Objective parameters alone have been also found to have no correlation with patient's satisfaction \[[@CR37]\], life background, since expectations and satisfaction are different for different individuals. Therefore, it is preferable for the LES to be used to evaluate the joint functions of patients with elbow stiffness by using self-assessment questionnaires in addition to physician-assessment parameters.

However, there are also some weaknesses that need to be realized when using the LES to evaluate joint function in patients with elbow stiffness. The researchers that invented the LES decided to remove the instability test from the objective parameters as they thought it was associated with a rare elbow problem. When presented, it would have such a massive impact on elbow function that it would be easily detected \[[@CR6]\]. However, according to our clinical experience, we believe that elbow instability is a perfect sign of collateral ligament dysfunction, which is a common complication in elbow trauma, and an indication for surgical therapeutic options and postoperative rehabilitation. Therefore, it would be better if instability was considered. For measuring strength as an elbow specific function, the MRC scale was used in most systems, as was the LES, which is a subjective qualitative assessment made by the surgeons. However, L Shahgholi. found that half of the patients clinically assessed as having normal (5/5) elbow flexion strength on manual muscle testing exhibited less than 42% of their age-expected strength on quantitative testing, as well as elbow extension strength testing. They concluded that even when performed by experienced clinicians, manual muscle testing may be more misleading than expected for subjects graded as having normal (5/5) strength \[[@CR38], [@CR39]\]. Therefore, measuring strength with a dynamometer would be a more objective and responsive measure than measuring strength with the MRC scale, and it could be measured over time and compared to normative data. Strength associated with grip, elbow and wrist motion are all necessary in assessing elbow function, especially in patients planning for elbow arthrolysis surgery, as reduced muscle strength is a common complication after arthrolysis \[[@CR40]\]. Additionally, pain has a strong impact on elbow function and health status measures \[[@CR41]\]. Due to the strong influence of psychological and sociological factors on the experience of pain, the expression of pain should probably be evaluated separately from objective parameters in physician-rated domains \[[@CR42]\]. Though the expression of pain is obtained from the PAQ portion of the LES, it comprises only 1/9 (\~ 11%) of the PAQ and 1/15 (\~ 7%) of the whole scores, which is in contrast to most of other scoring systems, in which pain is weighted as 30--50% of the total score \[[@CR4], [@CR5]\]. In fact, a five-level Likert scale could not fully generalize the expression of pain from patients and detect its changes from pre- to post-operation. We believe that these limitations may also contribute to its moderate responsiveness in the ERS. Finally, according to the International Classification of Functioning, Disability and Health (ICF), health and disability would be better measured in three domains: physician-rated body functions and structures, patient-rated activities and participation, and patient-rated quality of life \[[@CR43]\]. Unfortunately, LES does not include items inquiring about patients' qualities of life.

This study has some weaknesses. The biggest limitation of this study was that the test-retest reliability and internal consistency could not be validated due to the retrospective nature of the study, which is an important step (i.e. reliability) in evaluating a scoring system. The retrospective study could contribute to the bias in the validated results. Another limitation is that as it was a single-centre study, and it could not be said with certainty that these results could be applied to other centres. Therefore, further prospective research with a larger population from multiple clinical centres is needed.

Conclusion {#Sec12}
==========

Based on the present data, our results suggested that the LES is a valid elbow-specific scoring system and is applicable to evaluate joint functions of patients with elbow stiffness, although some items included had some weakness either. Further prospective research using a larger population from multiple clinical centres is required in future.
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